On 30 June 2019, Lola Ltd gained control of Charlie Ltd by purchasing all its share capital. On the control date, the fair values of Charlie Ltd's following assets differed from their carrying amounts: Carrying amount ($) Fair value ($) Accounts receivable 6 000 7 700 Inventory 82 000 84 000 Building (cost $240 000, with nil residual value) 210 000 200 000 Additional information: None of the above inventory was sold to external parties in the year ended 30 June 2020. The above building had a further 4 years' useful life at 30 June 2019. Charlie Ltd applied the cost model to buildings and continued to do so after the control date. The group and Charlie Ltd both apply straight-line depreciation to buildings. REQUIRED Prepare journal entries for the required consolidation data adjustments on 30 June 2020. Narrations (for journal entries) are not required. Please prepare your journal entries neatly. An illustrative example is provided below for the format of journal entries. Example only: Dr Interest expense 5000 Cr Interest payable 5000 On 30 June 2019, Lola Ltd gained control of Charlie Ltd by purchasing all its share capital. On the control date, the fair values of Charlie Ltd's following assets differed from their carrying amounts: Carrying amount ($) Fair value ($) Accounts receivable 6 000 7 700 Inventory 82 000 84 000 Building (cost $240 000, with nil residual value) 210 000 200 000 Additional information: None of the above inventory was sold to external parties in the year ended 30 June 2020. The above building had a further 4 years' useful life at 30 June 2019. Charlie Ltd applied the cost model to buildings and continued to do so after the control date. The group and Charlie Ltd both apply straight-line depreciation to buildings. REQUIRED Prepare journal entries for the required consolidation data adjustments on 30 June 2020. Narrations (for journal entries) are not required. Please prepare your journal entries neatly. An illustrative example is provided below for the format of journal entries. Example only: Dr Interest expense 5000 Cr Interest payable 5000